Interferon Alpha
Interferon Alpha is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
Cognitive Effects of Interferon in Patients With Melanoma
Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes
Clinical Trials (7)
Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
Cognitive Effects of Interferon in Patients With Melanoma
Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes
Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)
Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7